Company Overview and News

Sapura Energy to develop SK408 gas fields off Sarawak

2018-04-11 themalaymailonline
Sapura Energy says it has taken the final investment decision to develop Phase 1 of the SK408 Production Sharing Contract. — picKUALA LUMPUR, April 11 — Sapura Exploration and Production (Sarawak) Inc (Sapura E&P), a wholly-owned subsidiary of Sapura Energy Bhd, will develop the SK408 block comprising the Gorek, Larak, and Bakong gas fields offshore Sarawak together with its partners, Petronas Carigali Sdn Bhd and Sarawak Shell Bhd.
Upvote Downvote

UPDATE 1-UK Stocks-Factors to watch on April 10

2018-04-10 reuters
April 10 (Reuters) - Britain’s FTSE 100 index is seen opening 46 points higher at 7,240 on Tuesday, according to financial bookmakers with futures up 0.8 percent ahead of the cash market open.
Upvote Downvote

Analysts: Sapura Energy’s financial performance likely to improve next year

MIDF Research said in a report that Sapura Energy Berhad's earnings could improve, as the research house did not expect any major impairment to take place in FY19.
Upvote Downvote

European majors join race for Mexico oil bonanza in Gulf waters

2018-03-29 worldoil
Anglo-Dutch giant Royal Dutch Shell Plc, the UK’s BP Plc, France’s Total SA, Italy’s Eni SpA, Spain’s Repsol SA, Russia’s Lukoil PJSC and DEA Deutsche Erdoel AG of Germany all won blocks -- a number of them in partnership with state-owned Petroleos Mexicanos. Among notable absentees were U.S. majors like ExxonMobil Corp. and Chevron Corp., which have grabbed deep-water prospects in a previous round.
Upvote Downvote

European Majors Join Race for Mexico Oil Bonanza in Gulf Waters

2018-03-28 rigzone
(Bloomberg) -- European oil majors are swarming the shallow-waters of the Gulf of Mexico as the country races to attract investment before an election.
Upvote Downvote

[Press] Premier Oil: Award of Three Blocks in Mexico’s Round 3.1

2018-03-28 oilvoice
Premier is pleased to announce that it has been awarded Block 30 in the Sureste Basin and Blocks 11 and 13 in the Burgos Basin, in Mexico's Round 3.1 held in Mexico City on 27 March 2018.
Upvote Downvote

UPDATE 1-UK Stocks-Factors to watch on March 28

2018-03-28 reuters
March 28 (Reuters) - Britain’s FTSE 100 index is seen opening 53 points lower on Wednesday, according to financial bookmakers with futures down 0.6 percent ahead of the cash market open.
Upvote Downvote

Final Mexico Oil Auction Begins With Uneven Demand Ahead Of Election

2018-03-27 rigzone
MEXICO CITY, March 27 (Reuters) - Mexico awarded just under half of the 35 shallow-water blocks it tendered on Tuesday, in an auction muddied by the promises of the presidential frontrunner to review contracts awarded under a historic energy opening if he wins the July 1 election.
Upvote Downvote

Mexico awards all eight blocks in competitive Southeast Basins auction

2018-03-27 reuters
MEXICO CITY, March 27 (Reuters) - Mexico awarded all eight of the shallow-water blocks it tendered on Tuesday in the hard-fought final part of the last bidding round before the country’s July 1 presidential election.
Upvote Downvote

Repsol, Premier win oil block in last Mexico auction before election

2018-03-27 reuters
MEXICO CITY (Reuters) - Mexico on Tuesday kicked off its final energy auction before the July presidential election, tendering 35 shallow-water oil and gas blocks in a test of foreign producers’ interest in investing amid uncertainty over energy reforms.
Upvote Downvote

[Opinion] Oil Price, SDX Energy, Plexus Holdings, Columbus and Finally…

2018-03-26 oilvoice
Oil Price Last week ended up being a very good week for oil price bulls with WTI gaining $3.54 or 5.71% and Brent up $4.24 or 6.4%. Quite why and how this good news is not being reflected in the oil sector share prices I am at a total loss to understand. Fair enough, companies with only E and no P don't gain but there is a list of stocks in the bucket list with significant production that will be making out like the proverbial bandits especially after taking costs out by as much as 70% in the last three years.
Upvote Downvote

UPDATE 1-Mexico oil reserves dip again as private firms begin to contribute

2018-03-23 reuters
MEXICO CITY (Reuters) - Proven oil and gas reserves in Mexico fell again this year as new discoveries failed to keep pace with ongoing production, but officials pointed to the first-ever reserves contributed by private companies operating their own blocks as silver lining.
Upvote Downvote

Cairn Energy returns to profit as North Sea alliances pay off

Cairn Energy’s collaboration with two of the North Sea’s largest independent oil operators has paid off after driving the company back into profit.
Upvote Downvote

Premier Oil outshines loss with production outlook

Premier Oil has won over the City with a booming portfolio of North Sea assets despite slumping to a loss the last year in which its hefty debt pile barely budged.
Upvote Downvote

Premier Oil plc 2017 Q4 - Results - Earnings Call Slides

2018-03-09 seekingalpha
The following slide deck was published by Premier Oil plc in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...